Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozone plasma for COVID-19 pulmonary sequelae
NCT05089305Phase 2Unknown
- Sponsor
- Centro Universitario de Ciencias de la Salud
- Start
- Sep 2021
- Primary completion
- Nov 2022
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of ozone plasma in coronavirus disease 2019 (COVID-19), sponsored by Centro Universitario de Ciencias de la Salud. Status: unknown.
02
Drugs
ozone plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05089305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05089305.